• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 12TLW803F
Device Problems Burst Container or Vessel (1074); Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/26/2024
Event Type  malfunction  
Event Description
As reported, during use in patient of this fogarty embolectomy catheter, the balloon burst.The procedure was completed successfully.There was no allegation of patient injury.The device was available for evaluation.As per product evaluation, it was found the edges of latex did not appear to match up.Patient demographics unable to be obtained.
 
Manufacturer Narrative
One fogarty embolectomy catheter was received by our product evaluation laboratory for a full evaluation.As received, the balloon was found to be ruptured at the central area.The edges of latex did not appear to match up.Both balloon windings were intact.Through lumen was patent without any leakage or occlusion.No visible damage was observed from catheter body.The manufacturing records were reviewed for the lot involved and there is no indication of a related nonconformance.All process parameters were met and inspections passed successfully.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Patient demographics unable to be obtained.
 
Manufacturer Narrative
Added information to section d9 (date returned to manufacturer) and h6 (type of investigation) updated section h6 (device code), h6 (investigation findings) and h6 (investigations conclusions) as part of the manufacturing process the units go through a balloon and final inspection.The ifu was reviewed and it indicates: "balloon rupture and catheter separation as a result of excessive pull force applied to remove adherent material are the most frequent causes of reported failures." and "to minimize the risk of vessel damage, balloon rupture, or tip detachment, do not exceed the maximum recommended inflation and pull force for each size catheter." based on the available information there is no evidence that supports or confirms the failure is associated to a manufacturing or design defect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ARTERIAL EMBOLECTOMY CATHETER
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco
Manufacturer (Section G)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco
Manufacturer Contact
samantha eveleigh
1 edwards way
irvine, CA 92614
9492503939
MDR Report Key18912977
MDR Text Key337767645
Report Number2015691-2024-02042
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193379
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number12TLW803F
Device Lot Number65116232
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received03/15/2024
Supplement Dates Manufacturer Received03/26/2024
Supplement Dates FDA Received04/16/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/03/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-